研究者業績
基本情報
- 所属
- 藤田医科大学ばんたね病院 医学部 消化器外科学 准教授
- 学位
- 医学博士(2002年3月 藤田医科大学)
- 通称等の別名
- 許可する
- J-GLOBAL ID
- 201501000090924270
- researchmap会員ID
- 7000013244
- 外部リンク
研究分野
1論文
464-
Pathology international 2024年9月11日This study aimed to validate the DFS (direct fast scarlet) staining in the diagnosis of EC (eosinophilic colitis). The study included 50 patients with EC and 60 with control colons. Among the 60 control samples, 39 and 21 were collected from the ascending and descending colons, respectively. We compared the median number of eosinophils and frequency of eosinophil degranulation by HE (hematoxylin and eosin) and DFS staining between the EC and control groups. In the right hemi-colon, eosinophil count by HE was useful in distinguishing between EC and control (41.5 vs. 26.0 cells/HPF, p < 0.001), but the ideal cutoff value is 27.5 cells/HPF (high-power field). However, this method is not useful in the left hemi-colon (12.5 vs. 13.0 cells/HPF, p = 0.990). The presence of degranulation by DFS allows us to distinguish between the groups even in the left hemi-colon (58% vs. 5%, p < 0.001). DFS staining also enabled a more accurate determination of degranulation than HE. According to the current standard to diagnose EC (count by HE staining ≥20 cells/HPF), mucosal sampling from left hemi-colon is problematic since the number of eosinophils could not be increased even in EC. Determination of degranulated eosinophils by DFS may potentiate the diagnostic performance even in such conditions.
-
Fujita medical journal 10(3) 69-74 2024年8月OBJECTIVE: This study was performed to demonstrate the clinical application of duodenum-preserving pancreatic head resection (DPPHR) as a surgical treatment for pancreatic neuroendocrine tumors (PNETs) in terms of both curability and maintenance of postoperative quality of life. METHODS: Seven patients diagnosed with PNETs underwent DPPHR from January 2011 to December 2021 at our institution. We investigated the clinical relevance of DPPHR based on the patients' clinicopathological findings. RESULTS: The median operative time was 492 min, and the median blood loss was 302 g. Postoperative complications were evaluated according to the Clavien-Dindo classification, and postoperative intra-abdominal bleeding was observed in one patient. Pathological examination revealed a World Health Organization classification of G1 in six patients and G2 in one patient. Microvascular invasion was observed in two patients (29%); however, no patients developed lymph node metastasis or recurrence during the follow-up period. A daughter lesion was observed near the primary tumor in one patient. All patients achieved curative resection, and no tumor specimens showed positive margins. CONCLUSIONS: DPPHR facilitates anatomical resection of the pancreatic head in patients with PNETs as well as detailed pathological evaluation of the resected specimen. Therefore, this surgical procedure is an acceptable alternative to pancreaticoduodenectomy or enucleation for patients with PNETs.
-
胆膵の病態生理 40(1) 65-69 2024年6月症例は68歳男で、19年前に膵体部IPMNに対して膵中央切除+膵管-膵管吻合(Martin手術)を施行された。今回、心窩部痛を主訴に受診し、CTで膵管吻合部から尾側に乏血性腫瘤を認め、残膵癌が疑われた。諸検査の結果から、膵管吻合部に発生したDe novo膵癌が強く疑われたため、残膵切除術を行うこととした。膵切離を行い迅速病理に提出したところ腺癌陽性と診断されたため術式を膵全摘に変更し、術後経過は良好であった。
MISC
421書籍等出版物
2講演・口頭発表等
368-
胆と膵 2018年3月15日胆道癌取扱い規約第6版より、胆嚢癌の局所進展度はT1aとT1bに分類された。T1aは粘膜固有層への浸潤、T1bは固有筋層への浸潤を認めるものである。T1aの治療方針は、通常リンパ管侵襲、血管侵襲、リンパ節転移を認めないため胆嚢摘出術で問題ない。T1bの治療方針は、2017年に報告された2編のmeta解析の結果では、肝切除を伴った拡大胆嚢摘出術をすべきであるとの報告と胆嚢摘出術でよいとの報告がある。リンパ節郭清については、連続切片で検討した、2編の報告ではリンパ節転移を認めず、胆道癌取扱い規約第6版で規定された所属リンパ節郭清は必要はない。T1胆嚢癌に対する腹腔鏡手術は、現時点では推奨されず、原則として開腹胆嚢摘出術を行うべきである。腹腔鏡手術に対する質の担保された研究が、近年、少数ではあるが報告されてきており、今後の大規模な研究が待たれるところである。(著者抄録)